Qualigen-Logo-Tag.png
Qualigen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 08, 2021 07:30 ET | Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with...
Form fit function.png
Conformis, Inc. to Participate in Upcoming Investor Conferences
September 07, 2021 17:00 ET | Conformis, Inc.
BILLERICA, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features a range of personalized knee and hip replacement products,...
VIR_logo_large.jpg
Vir Biotechnology to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021 16:05 ET | Vir Biotechnology, Inc.
SAN FRANCISCO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Howard Horn, chief financial officer, is scheduled to present at the H.C. Wainwright 23rd...
final+logo.jpg
Innovative Payment Solutions to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
September 07, 2021 09:25 ET | Innovative Payment Solutions, Inc.
CARMEL, CA, Sept. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Innovative Payment Solutions, Inc. (OTCQB: IPSI) (“Innovative” or the “Company”), a California-based fintech company focused on...
2019 logo_150x35_jpg.jpg
Novan to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021 09:00 ET | Novan, Inc.
DURHAM, N.C., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan,...
Logo.jpg
INVECTYS INC. TO PARTICIPATE IN THE 2021 H.C. WAINWRIGHT 23rd ANNUAL GLOBAL INVESTMENT CONFERENCE SEPTEMBER 13-15, 2021
September 07, 2021 09:00 ET | Invectys, Inc.
Houston, Texas, USA, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of products...
Obseva Logo highresolution.jpg
ObsEva to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021 01:00 ET | ObsEva SA
GENEVA, Switzerland September 7, 2021 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...
logo.png
SOCIAL LIFE NETWORK ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 23rd Annual Global Investment Conference
September 03, 2021 14:22 ET | Social Life Network, Inc.
LOS ANGELES, CA, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Social Life Network, Inc. (OTC: WDLF) today announced it will be featured as a presenting company at the H.C. Wainwright 23rd Annual Global...
Logo.png
Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th
June 16, 2021 09:15 ET | Protagenic Therapeutics, Inc.
NEW YORK , June 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a bioharmaceutical company focused on developing drug product candidates to treat stress-related neurologic...
2019 logo_150x35_jpg.jpg
Novan to Present at the H.C. Wainwright Global Life Sciences Conference
March 05, 2021 09:00 ET | Novan, Inc.
MORRISVILLE, N.C., March 05, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of...